Nab paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after failure of folfirinox: Results of an AGEO multicenter prospective cohort

Autor:	Alix Portal, Jean-Baptiste Bachet, Olivier Dubreuil, Julien Taieb, Johann Dreanic, David Tougeron, Lysiane Marthey, Romain Coriat, Jean-Louis Legoux, Claire Arbaud, Pascal Hammel, Thierry Lecomte, Céline Lepère, Laetitia Dahan, Anne Thirot-Bidault, Philippe Rougier, Christophe Locher, Franck Bonnetain, Christelle De La Fouchardiere, Simon Pernot
Rok vydání:	2015
Předmět:	Oncology Cancer Research medicine.medical_specialty endocrine system diseases FOLFIRINOX business.industry Metastatic Pancreatic Adenocarcinoma Gemcitabine Internal medicine medicine Prospective cohort study business Nab-paclitaxel medicine.drug
Zdroj:	Journal of Clinical Oncology. 33:4123-4123
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2015.33.15_suppl.4123
Popis:	4123 Background: Both Folfirinox and Nab-paclitaxel plus Gemcitabine showed a benefit in terms of survival in first-line treatment of metastatic pancreatic adenocarcinoma (MPA) when compared to gem...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::8ec8213c8888ccafcd3c46c15a81697e https://doi.org/10.1200/jco.2015.33.15_suppl.4123 Zobrazit plný text záznamu